Target intelligence / Profile preview

Thickening of cervical mucus

Molecular classification
Other (physiological process, not a protein or receptor)
01

Overview

Thickening of cervical mucus is a physiological process, not a molecule or protein, wherein the viscosity of the mucus produced by the cervical epithelium increases, typically under the influence of progesterone or exogenous progestins. This thicker mucus acts as a barrier to sperm and pathogens, reducing the likelihood of fertilization and protecting the upper reproductive tract. Some drug interventions, both hormonal (progestins) and non-hormonal (certain gels or ion channel inhibitors), target this process to achieve contraceptive effects by making sperm penetration more difficult. Disease states like cystic fibrosis can pathologically increase mucus thickness due to defective ion channel function. The process itself is an endpoint or mechanism of a contraceptive action, not a pharmacological target in the classic sense. Thickening of cervical mucus is not a canonical molecular target; it is a physiological change mediated by other targets (mostly hormonal receptors or mucin/ion channel regulation). If you are seeking structured data for drug-molecule/receptor mapping, this entry does not fit. The true targets are typically the progesterone receptor (for hormonal induction) or CFTR channel (for ion regulation), and structured data should be mapped to these.

Other names
Increased viscosity of cervical mucusCervical mucus thickeningMucus plug formationViscous cervical mucus
02

Mechanism of action

Hormonal: Progestins bind the progesterone receptor, leading to the production of thick, impermeable mucus—impeding sperm transport. Ion channel inhibition: Inhibition of CFTR channel reduces hydration of mucus, resulting in increased viscosity. Non-hormonal gel: Polymers physically increase mucus viscosity, blocking sperm penetration.

03

Biological functions

Barrier to sperm penetrationBarrier to pathogen entryModulation of fertility (contraception)
04

Disease associations

Other (infertility, contraception, infection prevention)
05

Safety considerations

Excessive thickening may predispose to infection or hinder necessary cervical mucus functions (e.g., in cystic fibrosis)Non-specificity: Systemic drugs may cause off-target endocrine effects
06

Interacting drugs

Progestins and progestogen-based contraceptives (e.g., levonorgestrel, etonogestrel)

2 more in the full profile.

07

Biomarkers

Physical properties of mucus: viscosity, spinnbarkeit, ferning patternsMucin glycoprotein expression and composition (e.g., MUC5B, MUC5AC)

Beyond the preview

Go deeper on Thickening of cervical mucus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thickening of cervical mucus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call